Xenoport (XNPT)

Analysts are forecasting triple-digit growth for this biopharma company this year. Our other two recommendations today are sells on stocks that aren’t fulfilling expectations. Buy: Xenoport (XNPT) From The Periscope Report Xenoport (XNPT) is a biopharmaceutical company that focuses on developing a portfolio of product for...
Read More